fluindione has been researched along with acenocoumarol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoura, Z; Ankri, A; Aymard, G; Cacoub, P; Costedoat-Chalumeau, N; Diquet, B; Du, LT; Piette, JC; Sevin, O; Wechsler, B | 1 |
| Boneu, B; Léger, P | 1 |
| Doubine, S; Losay, J; Piquet, P | 1 |
| Belle, L; Berry, C; Desjoyaux, E; Gonod, M; Picard, A; Poiré, V; Saligari, E; Vialle, E | 1 |
| Arnon, J; Clementi, M; De Santis, M; Dolivo, A; Eléfant, E; Hannemann, D; Meister, R; Merlob, P; Paulus, W; Reuvers, M; Robert-Gnansia, E; Rodriguez-Pinilla, E; Schaefer, C; Vial, T | 1 |
| Ansell, J; Caro, J; Drouet, L; Hollowell, J; Martinez-Brotons, F; Pengo, V | 1 |
| Bernard, P; Bezier, M; Durlach, A; Grange, F; Nguyen, P; Perceau, G; Reguiai, Z; Remy-Leroux, V; Tchen, T | 1 |
| Becquemont, L; Delavenne, X; Diquet, B; Jaillon, P; Lebot, M; Robert, A; Rousseau, A; Tod, M; Verstuyft, C | 1 |
| Bron, AM; Creuzot-Garcher, C; Juniot, A; Koehrer, P; Passemard, M | 1 |
| Ammentorp, B; Darius, H; De Caterina, R; Kirchhof, P; Le Heuzey, JY; Schilling, RJ; Schmitt, J; Zamorano, JL | 1 |
| Auffret, M; Béné, J; Caron, J; Dubart, AE; Gautier, S; Senis, C | 1 |
| Sakaan, S; Sands, CW; Self, TH; Wallace, JL | 1 |
| Bertrand, M; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M | 1 |
| Howard-Thompson, A; Owens, RE; Sakaan, SA; Sands, CW; Self, TH; Wallace, JL | 1 |
| Bagheri, H; Béné, J; Gautier, S; Lambert, M; Rousselin, C; Vial, T | 1 |
| Caré, B; Laroche, JP; Quéré, I; Schved, JF; Valdelièvre, E | 1 |
| Désage, S; Jourdy, Y; Jousselme, E; Le Quellec, S; Négrier, C; Nougier, C | 1 |
4 review(s) available for fluindione and acenocoumarol
| Article | Year |
|---|---|
[Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics].
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Drug Interactions; Family Practice; Food; Hemorrhage; Humans; Patient Education as Topic; Phenindione; Thrombosis; Time Factors; Vitamin K; Warfarin | 2002 |
[Evaluation of an education program of patients undergoing oral anticoagulation treatment].
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Chi-Square Distribution; Data Interpretation, Statistical; Female; Heart Diseases; Humans; Male; Middle Aged; Patient Education as Topic; Patient Satisfaction; Phenindione; Surveys and Questionnaires; Thromboembolism; Time Factors; Vitamin K | 2003 |
Effect of Body Weight on Dose of Vitamin K Antagonists.
Topics: Acenocoumarol; Anticoagulants; Body Weight; Comorbidity; Drug Dosage Calculations; Humans; Obesity; Obesity, Morbid; Phenindione; Phenprocoumon; Vitamin K; Warfarin | 2015 |
Effect of diseases on response to vitamin K antagonists.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Cardiovascular Diseases; Diarrhea; Fibrinolytic Agents; Heart Failure; Humans; Hyperthyroidism; Kidney Failure, Chronic; Liver Diseases; Obesity; Phenindione; Phenprocoumon; Vitamin K; Warfarin | 2016 |
1 trial(s) available for fluindione and acenocoumarol
| Article | Year |
|---|---|
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.
Topics: Acenocoumarol; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Body Weight; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; International Normalized Ratio; Male; Mixed Function Oxygenases; Models, Biological; Phenindione; Polymorphism, Genetic; Smoking; Vitamin K Epoxide Reductases | 2012 |
12 other study(ies) available for fluindione and acenocoumarol
| Article | Year |
|---|---|
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Blood Coagulation Factors; Drug Synergism; Female; Humans; Infusions, Intravenous; International Normalized Ratio; Male; Methylprednisolone; Middle Aged; Phenindione; Prospective Studies; Protein C; Protein S; Prothrombin Time; Vitamin K | 2000 |
[Acenocoumarol (Sintrom) and fluinidione (Previscan) in pediatrics after cardiac surgical procedures].
Topics: Acenocoumarol; Administration, Oral; Adolescent; Anticoagulants; Cardiovascular Surgical Procedures; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Phenindione; Postoperative Care; Postoperative Complications; Retrospective Studies | 2002 |
Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Acenocoumarol; Adverse Drug Reaction Reporting Systems; Anticoagulants; Birth Weight; Female; Fetal Diseases; Gestational Age; Humans; Phenindione; Phenprocoumon; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies; Vitamin K; Warfarin | 2006 |
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Canada; Cohort Studies; Drug Monitoring; Female; France; Humans; International Normalized Ratio; Italy; Male; Middle Aged; Phenindione; Practice Patterns, Physicians'; Quality of Health Care; Retrospective Studies; Spain; Stroke; Treatment Outcome; United States; Warfarin | 2007 |
[Necrotic leg ulcers induced by vitamin K antagonists: five cases].
Topics: Acenocoumarol; Activated Protein C Resistance; Aged; Aged, 80 and over; Anticoagulants; Diabetic Angiopathies; Factor V; Female; Humans; Hyperhomocysteinemia; Leg Ulcer; Male; Necrosis; Phenindione; Polyarteritis Nodosa; Postoperative Complications; Purpura; Thrombophilia; Varicose Ulcer; Vasculitis, Leukocytoclastic, Cutaneous; Vitamin K | 2011 |
Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Clopidogrel; Conscious Sedation; Electrocardiography; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Orbit; Oximetry; Phenindione; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Ticlopidine; Vitreoretinal Surgery; Warfarin; Young Adult | 2012 |
Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Europe; Female; Humans; Male; Middle Aged; Phenindione; Phenprocoumon; Practice Guidelines as Topic; Registries; Vitamin K; Warfarin; Withholding Treatment | 2014 |
Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Drug Interactions; Emergency Service, Hospital; Female; Genetic Predisposition to Disease; Hemorrhage; Humans; International Normalized Ratio; Male; Phenindione; Respiration Disorders; Risk Factors; Secondary Care Centers; Thrombosis; Vitamin K; Warfarin | 2014 |
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Phenindione; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin | 2015 |
Nonhemorrhagic joint disorders and vitamin K antagonists: an under-recognized adverse drug reaction?
Topics: Acenocoumarol; Aged; Anticoagulants; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Joint Diseases; Male; Middle Aged; Pharmacovigilance; Phenindione; Vitamin K; Warfarin | 2018 |
[Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Topics: Acenocoumarol; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Female; Humans; International Normalized Ratio; Male; Middle Aged; Phenindione; Risk Factors; Sex Factors; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2018 |
Single-center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Tests; Factor X; Female; Humans; Male; Middle Aged; Phenindione; Prothrombin; Reference Values; Vitamin K; Warfarin | 2019 |